Discovery of novel synthetic IL-1 adjuvants

NIH RePORTER · NIH · N01 · $2,613,001 · view on reporter.nih.gov ↗

Abstract

To identify the optimal adjuvant for recombinant vaccines and inactivated flu vaccines, and to identify correlates of protection against infection or disease, experimental vaccines will be formulated with a panel of different vaccine adjuvants and tested side-by-side for immunogenicity and efficacy.

Key facts

NIH application ID
10610274
Project number
75N93019C00045-P00012-9999-1
Recipient
UNIVERSITY OF MONTANA
Principal Investigator
JAY EVANS
Activity code
N01
Funding institute
NIH
Fiscal year
2022
Award amount
$2,613,001
Award type
—
Project period
2021-09-30 → 2022-09-29